4//SEC Filing
Baldasare Bryan T 4
Accession 0001127602-21-004586
CIK 0000794172other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 1:26 PM ET
Size
8.5 KB
Accession
0001127602-21-004586
Insider Transaction Report
Form 4
Baldasare Bryan T
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-08$19.56/sh+3,750$73,350→ 62,382 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-02-08−3,750→ 0 totalExercise: $19.56Exp: 2026-03-24→ Common Stock (3,750 underlying) - Sale
Common Stock
2021-02-08$30.00/sh−6,254$187,620→ 56,128 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F2]The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F3]These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020.
Documents
Issuer
MERIDIAN BIOSCIENCE INC
CIK 0000794172
Entity typeother
Related Parties
1- filerCIK 0001761920
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 1:26 PM ET
- Size
- 8.5 KB